The United States of America, As Represented by the Secretary, Department of Health and Human Services

De-Qi Xu

Dennis J Kopecko

John O Cisar

The invention relates toTy21a comprising core-linkedserotype 1 O-specific polysaccharide (O-Ps) and DNA encoding O antigen biosynthesis, said DNA selected from the group consisting of: a) the DNA sequence set out in any one of SEQ ID NOs: 1 and 2 and species homologs thereof; b) DNA encodingserotype 1 polypeptides encoded by any one of SEQ ID NOs: 1 and 2, and species homologs thereof; and c) DNA encoding a O antigen biosynthesis gene product that hybridizes under moderately stringent conditions to the DNA of (a) or (b); and related sequences, compositions of matter, vaccines, methods of using, and methods of making.

[object Object]

Compositions and methods for protecting a susceptible host against an infection ofare disclosed. Such compositions and methods are useful for protecting the host against bacillary dysentery and shigellosis.

Compositions and methods for protecting a susceptable host against an infection ofare disclosed. Such compositions and methods are useful for protecting the host against bacillary dysentery and shigellosis.

Growing community of inventors

Columbia, MD, United States of America

De-Qi Xu